News
U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
Weekend Woman’s Hour: Natalie Fleet MP, HIV prevention, Trisha Goddard, Older surrogacy, Comedian Rosie Jones ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback